COMMUNICATION
Bcl-XL Cooperatively Associates with the Bap31 Complex in the Endoplasmic Reticulum, Dependent on Procaspase-8 and Ced-4 Adaptor*

Florence W. H. Ng and Gordon C. ShoreDagger

From the Department of Biochemistry, McGill University, Montreal, Quebec H3G 1Y6, Canada

    ABSTRACT
Top
Abstract
Introduction
Procedures
Results & Discussion
References

Bap31 is a polytopic integral membrane protein of the endoplasmic reticulum and forms a complex with Bcl-2/Bcl-XL and procaspase-8 (Ng, F. W. H., Nguyen, M., Kwan, T., Branton, P. E., Nicholson, W. D., Cromlish, J. A., and Shore, G. C. (1997) J. Cell Biol. 139, 327-338). In co-transfected human cells, procaspase-8 is capable of interacting with Ced-4, an important adaptor molecule in Caenorhabditis elegans that binds to and activates the C. elegans procaspase, proCed-3. Here, we show that the predicted death effector homology domain within the cytosolic region of Bap31 interacts with Ced-4 and contributes to recruitment of procaspase-8. Bcl-XL, which binds directly but weakly to the polytopic transmembrane region of Bap31, indirectly and cooperatively associates with the Bap31 cytosolic domain, dependent on the presence of procaspase-8 and Ced-4. Ced-4Delta c does not interact with Bcl-XL but rather displaces it from Bap31, suggesting that an endogenous Ced-4-like adaptor is a normal constituent of the Bap31 complex and is required for stable association of Bcl-XL with Bap31 in vivo. These findings indicate that Bap31 is capable of recruiting essential components of a core death regulatory machinery.

    INTRODUCTION
Top
Abstract
Introduction
Procedures
Results & Discussion
References

Genetic studies in the nematode Caenorhabditis elegans have identified and ordered a core machinery for regulation of apoptotic programmed cell death in which the Bcl-2 homolog, Ced-9, prevents Ced-4 from activating the caspase, Ced-3, and thus blocks ensuing cell death (1-4). Recent reconstitution of these events both in vitro and in heterologous yeast and human cells has revealed that Ced-9 directly binds and sequesters Ced-4 (5-9), which in turn remains associated with Ced-3 (6, 9). This presumably prevents the Ced-4 adaptor from triggering autocatalytic processing and activation of Ced-3 (10, 11). Of note, when expressed in human cells, Ced-4 is also capable of mechanically linking the Bcl-2 family protein, Bcl-XL, to procaspase-8 (6). Ced-4 likely achieves this by substituting for an endogenous Ced-4-like adaptor molecule that otherwise would connect Bcl-XL and procaspase-8 (6). Caspase-8 (12-14) belongs to the initiator class of caspases (14-16) whose members appear to function upstream of mitochondria (17) to activate the death pathway. Significantly, Ced-4 itself does not associate with procaspase-3 (6), a downstream effector caspase whose activation may depend on a combination of mitochondrial-released factors and the Ced-4-like cytosolic protein, Apaf-1 (Ref. 18 and reviewed in Ref. 19). A major question, however, is the mechanism by which these Ced-4 controlled events are linked to the plethora of signals that result in activation of caspases and subsequent cell death.

Recently, we identified a Bcl-2/Bcl-XL and procaspase-8 associated protein in the endoplasmic reticulum (ER),1 p28 Bap31 (20). Bcl-2 family proteins are located in the ER/nuclear envelope and mitochondrial outer membrane (21-23) and, in the latter location, appear to prevent activation of downstream effector caspases such as procaspase-3 in response to diverse death signals (see Refs. 19 and 24). Initiator caspases such as procaspase-8, on the other hand, are well characterized constituents of the Fas and TNFR1 apoptosis signaling complexes in the plasma membrane (25-27). These complexes, however, are highly restricted in the death signals to which they respond and are not directly influenced by Bcl-2 family proteins. The ability of Bap31 to associate with both procaspase-8 and Bcl-2/Bcl-XL, therefore, raises the possibility that the Bap31 complex in the ER might cooperate with events in the mitochondrion to control proximal and distal steps in a Bcl-2-regulated caspase cascade. If so, the ability of Ced-4 to bridge Bcl-XL and procaspase-8 (6) predicts that a Ced-4-like adaptor molecule may also be a part of the Bap31 complex.

    EXPERIMENTAL PROCEDURES
Top
Abstract
Introduction
Procedures
Results & Discussion
References

Plasmids-- cDNAs encoding proteins tagged with specific epitopes were constructed in expression vectors. Flag epitope was inserted toward the C terminus of Bap31, immediately upstream of the KKEE ER retrieval signal; Myc and HA epitopes were placed at the C termini of Bcl-XL and proFLICE, respectively. Details are provided in Ref. 20. Standard recombinant DNA methodology was employed to create pCDNA3.1 vectors (Invitrogen) encoding Bap31Delta N119, lacking amino acids 2-119, and Bap31Delta 167-240, lacking amino acids 167-240. Authenticity of all constructs was validated by sequence analysis. Similarly, pGEX 2T vectors (Invitrogen) encoding GST and GST-Bap31Delta N119 were employed to express the proteins in bacteria, which were purified as described in refs. 20 and 30. The coding region of Ced-4S (28) was obtained by reverse transcription-polymerase chain reaction using total C. elegans RNA and 5'-CGAGGTACCATGCTCTGCGAAATCGA-3' as the sense primer and 5'-CGAGGTACCTCAAGCGTAATCTGGAACATCGTATGGGTAACAGCATGCAAAATTTTTG-3' as antisense primer, and the construct was inserted into pCDNA3.1 by standard manipulations. Reverse transcription-polymerase chain reaction was employed to delete the region encoding amino acids 303-548, using 5'-CTAGAATACCCATACGATGTTCCAGATTACGCTTAAGGTACCGC-3' as sense primer and 5'-GGCCGCGGTACCTTAAGCGTAATCTGGAACATCGTATGGGTATT-3' as antisense primer.

Transfections and Immunoprecipitation-- Details concerning transfection of expression vectors into human 293T cells, subsequent preparation of cell lysates, and analysis of products by immunoprecipitation followed by transfer to nitrocellulose for immunoblot analysis are given in Ref. 20.

    RESULTS AND DISCUSSION
Top
Abstract
Introduction
Procedures
Results & Discussion
References

The predicted death effector homology domain in Bap31 (amino acids 165-238) is flanked on either side by sites that are cleaved by caspase-8 or a related caspase during adenovirus E1A-induced apoptosis (20) (summarized in Fig. 1A). The resulting p20 Bap31 product is a potent inducer of apoptosis when expressed ectopically in otherwise normal cells, presumably because it has a dominant-negative effect on endogenous Bap31 (20). In vitro mapping has revealed that Bcl-2 proteins bind directly to the N-terminal domain of Bap31, which includes the polytopic membrane-associated region, and weakly if at all with the cytosolic domain (20). As expected, therefore, full-length Flag-tagged Bap31, but not the Bap31 cytosolic domain alone (Bap31Delta N119), interacted with Bcl-XL in co-transfected human 293T cells, as judged by co-immunoprecipitation with anti-Flag antibody (Fig. 1B, compare lanes 3 and 4). However, when Bap31Delta N119 was coexpressed with both Bcl-XL and procaspase-8 (proFLICE), a strong association between Bcl-XL and the Bap31 cytosolic domain was recorded (lane 5). Thus, Bcl-XL may be tethered at the N terminus of Bap31 and associate indirectly and cooperatively with the Bap31 cytosolic domain, dependent on the presence of procaspase-8. Failure to achieve reconstitution of these interactions in vitro (not shown), however, suggested that an adaptor molecule might be required.


View larger version (17K):
[in this window]
[in a new window]
 
Fig. 1.   Procaspase-8 (proFLICE) promotes an indirect association of Bcl-XL with the cytosolic domain of Bap31. A, topology and domain structure of Bap31. The orientation of the three transmembrane segments of Bap31 predicts a Nlumen-Ccyto topology in the ER membrane (20). The region of the 13-kDa cytosolic domain containing putative death effector homology (D) and leucine zipper (Z) domains, flanked on either side by caspase-8 recognition sites (asterisks), are boxed. Amino acid positions (aa) used for generating deletion mutants are indicated. Flag epitope was inserted immediately upstream of the C-terminal KKEE ER retrieval signal (20). B, cooperative association of Bcl-XL and procaspase-8 (proFLICE) with the Bap31 cytosolic domain. Human embryonic kidney 293T cells were transfected with vectors encoding the indicated epitope-tagged proteins (20), and total cell extracts (lysate) containing similar levels of either Bap31-Flag or Bap31Delta N119-Flag were prepared 30 h later; immunoprecipitations (ip) obtained with mouse M2 anti-Flag antibody (IBI-A Kodak) were resolved by 12% SDS-PAGE, blotted onto nitrocellulose, and developed with anti-Myc 9E10 antibody (Babco) to detect Bcl-XL, which was visualized by enhanced chemoluminescence. Experimental details are provided in Ref. 20.

As a preliminary step indicating that Ced-4 might associate with Bap31, a transcription-translation product of the proapoptotic short splice form of Ced-4 (28) was found to interact in vitro with a glutathione S-transferase fusion protein containing the Bap31 cytosolic domain (GST-Bap31Delta N119) (Fig. 2). Furthermore, when Ced-4 was co-expressed with Bap31-Flag in 293T cells and total cell extracts were incubated with anti-Flag antibody, Ced-4 co-immunopreciptated with Bap31-Flag but not with Control-Flag (Fig. 3A, lanes 3 and 4). This association was significantly reduced using a Bap31 construct lacking the putative death effector homology domain (Bap31Delta 167-240-Flag, lane 2). In fact, the residual amount of Ced-4 that was recovered in association with the Bap31 deletion mutant (lane 2) may have resulted because immunoprecipitation of Bap31Delta 167-240-Flag with anti-Flag antibody also precipitated endogenous Bap31 (lanes 7). The latter is consistent with our findings that Bap31 forms homooligomers both in vitro and in vivo.2 Of note, expression of Ced-4 did not lead to significant caspase-dependent cleavage of Bap31. This is concordant with the observation that Ced-4 does not independently induce apoptosis in 293T cells (9).


View larger version (43K):
[in this window]
[in a new window]
 
Fig. 2.   Binding of Ced-4 to the Bap31 cytosolic domain in vitro. cDNAs encoding Ced-4 or Control protein were constructed in Bluescript, and the 35S-labeled proteins were generated by transcription-translation in rabbit reticulocyte lysate as described (30). Following incubation with equivalent amounts of GST (lanes 6-8) or GST-Bap31Delta N119 (lanes 3-5) linked to glutathione Sepharose, the associated translation product was recovered and visualized by SDS-PAGE and fluorography as described (20, 30). Lanes 1 and 2, 10% of input Ced-4 and Control protein, respectively.


View larger version (24K):
[in this window]
[in a new window]
 
Fig. 3.   Ced-4 interacts with Bap31 in 293T cells. A, Ced-4 associates with the cytosolic domain of Bap31. 293T cells were transfected with the indicated vectors, and after 30 h, protein complexes were recovered from cell extracts (lysate) with anti-Flag antibody (Flag ip), resolved by SDS-PAGE, transferred to nitrocellulose, and treated with either anti-HA (alpha  HA) antibody to detect Ced-4 (lanes 1-6) or chicken anti-Bap31 (alpha  p28-M; Ref. 20) (lanes 7-9) to detect Bap31 (Fig. 1). B, as in A, except that protein complexes were recovered from cell extracts (lysate) with anti-Flag antibody (Flag ip), and Ced-4 and procaspase-8 (proFLICE) visualized with anti-HA antibody. C, as in A and B, except that the association of procaspase-8 (proFLICE) with Bap31 and Bap31Delta 167-240 was determined.

Importantly, the presence of Bcl-XL did not influence the ability of Ced-4 to associate with Bap31 in 293T cells (Fig. 3A, lanes 4 and 6), suggesting that Bcl-XL does not function to prevent Ced-4 from engaging the Bap31 complex. Moreover, this was also extended to procaspase-8, where it was found that Ced-4 and procaspase-8, when expressed individually in co-transfected 293T cells, associated with Bap31-Flag (Fig. 3B, lanes 3 and 5) to the same extent as in the situation where Ced-4 and procaspase-8 were expressed together (lane 7). Again, as was the case for Ced-4 (Fig. 3A), the ability of procaspase-8 to associate with Bap31 was significantly reduced by deleting the putative Bap31 death effector homology domain (Fig. 3C).

One obvious explanation to account for the ability of Ced-4 to associate with the Bap31 complex is that Ced-4 may be substituting for an endogenous Ced-4-like adaptor molecule. Earlier studies identified a means of testing this hypothesis (Ref. 6, see schematic in Fig. 4). A mutant Ced-4 lacking the C-terminal 248 amino acids, Ced4Delta c, failed to interact with Ced-9 or Bcl-XL but retained the ability to associate with Ced-3 or procaspase-8 in co-transfected 293T cells. Thus, it competes in vivo with an endogenous adaptor that bridges Bcl-XL and procaspase-8 and prevents precipitation of procaspase-8 by an antibody directed to Bcl-XL (6). Similarly, we found that Ced-4Delta c lacking the C-terminal 246 amino acids also competed for the ability of Bcl-XL to bind to Bap31 in vivo (Fig. 4, lanes 1 and 3, upper panel), strongly implying that it does so by displacing an endogenous adaptor that otherwise would make contact with Bcl-XL. Wild-type Ced-4 also reduced somewhat the level of Bcl-XL that was recovered with Bap31 (lanes 1 and 2), suggesting that Ced-4 is less efficient than the endogenous adaptor molecule at contributing to the association of Bcl-XL with the Bap31 complex. Taken together, the results in Fig. 4 and those in Fig. 1B demonstrate that cooperative interactions between Bcl-XL and both Ced-4 and procaspase-8 contribute to the stable binding of Bcl-XL to Bap31 in vivo.


View larger version (32K):
[in this window]
[in a new window]
 
Fig. 4.   Ced-4Delta c displaces Bcl-XL from the Bap31 complex. 293T cells were transfected with vectors encoding the indicated proteins, and 30 h later, cell extracts (lysate) were prepared, protein complexes were isolated with anti-Flag antibody (alpha  Flag ip), and the presence of Bcl-XL (alpha  Myc), Ced-4 or Ced-4Delta c (alpha  HA), and Bap31 (alpha  Bap31 using the p28-M antibody) was assessed following SDS-PAGE and immunoblotting as described in the legends to Figs. 1 and 3. See the text for a description of the schematic above the figure.

In conclusion, the ability of Ced-9 to bind to and prevent Ced-4 from activating Ced-3 provides a simple explanation to account for the molecular control over apoptotic cell death. Nevertheless, it remains to be explained how the corresponding molecular complexes in mammalian cells are linked to the multitude of signals that can trigger activation of procaspases and how they interface with the numerous proapoptotic and antiapoptotic regulators that modulate these signals (24, 29). The cooperative associations between Bcl-XL, Ced-4, procaspase-8, and the Bap31 cytosolic domain observed here, on the other hand, suggest that Bap31 may provide one such bridge and predict that an endogenous Ced-4-like adaptor molecule may be a normal constituent of the Bap31 complex.

    ACKNOWLEDGEMENTS

We are grateful to Mai Nguyen, Phil Branton, John Bergeron, and Josée Lavoie for discussions and to Siegfried Hekimi for providing C. elegans RNA.

    FOOTNOTES

* This work was supported by operating grants from the National Cancer Institute and the Medical Research Council of Canada.The costs of publication of this article were defrayed in part by the payment of page charges. The article must therefore be hereby marked "advertisement" in accordance with 18 U.S.C. Section 1734 solely to indicate this fact.

Dagger To whom correspondence should be addressed. Tel.: 514-398-7282; Fax: 514-398-7384; E-mail: shore{at}medcor.mcgill.ca.

1 The abbreviations used are: ER, endoplasmic reticulum; PAGE, polyacrylamide gel electrophoresis; GST, glutathione S-transferase; HA, hemagglutinin.

2 F. W. H. Ng and G. C. Shore, unpublished observation.

    REFERENCES
Top
Abstract
Introduction
Procedures
Results & Discussion
References

  1. Yuan, J.-Y., and Horvitz, R. H. (1990) Dev. Biol. 138, 33-41[Medline] [Order article via Infotrieve]
  2. Hengartner, M. O., Ellis, R. E., and Horvitz, R. H. (1992) Nature 356, 494-499[CrossRef][Medline] [Order article via Infotrieve]
  3. Shaham, S., and Horvitz, R. H. (1996) Genes Dev. 10, 578-591[Abstract]
  4. Hengartner, M. O. (1996) Curr. Opin. Genet. Dev. 6, 34-38[Medline] [Order article via Infotrieve]
  5. Wu, D., Wallen, H. D., and Nuñez, G. (1997) Science 275, 1126-1129[Abstract/Free Full Text]
  6. Chinnaiyan, A. M., O'Rourke, K., Lane, B. R., Dixit, V. M. (1997) Science 275, 1122-1126[Abstract/Free Full Text]
  7. Spector, M. S., Desnoyers, S., Hoeppner, D. J., Hengartner, M. O. (1997) Nature 385, 653-656[CrossRef][Medline] [Order article via Infotrieve]
  8. James, C., Gschmeissner, S., Fraser, A., and Evan, G. I. (1997) Curr. Biol. 7, 246-252[Medline] [Order article via Infotrieve]
  9. Wu, D., Wallen, H. D., Inohara, N., and Nuñez, G. (1997) J. Biol. Chem. 272, 21449-21454[Abstract/Free Full Text]
  10. Chinnaiyan, A. M., Chaudhary, D., O'Rourke, K., Koonin, E. V., Dixit, V. M. (1997) Nature 388, 728-729[CrossRef][Medline] [Order article via Infotrieve]
  11. Seshagiri, S., and Miller, L. K. (1997) Curr. Biol. 7, 455-460[Medline] [Order article via Infotrieve]
  12. Boldin, M. P., Goncharov, T. M., Goltsev, Y. V., Wallach, D. (1996) Cell 85, 803-815[Medline] [Order article via Infotrieve]
  13. Muzio, M., Chinnaiyan, A. M., Kischkel, F. C., O'Rourke, K., Shevchenko, A., Ni, J., Scaffidi, C., Bretz, J. D., Zhang, M., Gentz, R., Mann, M., Krammer, P. H., Peter, M. E., Dixit, V. M. (1996) Cell 85, 817-827[Medline] [Order article via Infotrieve]
  14. Srinivasula, S. M., Ahmad, M., Fernandes-Alnemri, T., Litwack, G., and Alnemri, E. S. (1996) Proc. Natl. Acad. Sci. U. S. A. 93, 14486-14491[Abstract/Free Full Text]
  15. Fernandes-Alnemri, T., Armstrong, R. C., Krebs, J., Srinivasula, S. M., Wang, L., Bullrich, F., Fritz, L. C., Trapani, J. A., Tomaselli, K. J., Litwack, G., Alnemri, A. (1996) Proc. Natl. Acad. Sci. U. S. A. 93, 7464-7469[Abstract/Free Full Text]
  16. Muzio, M., Salvensen, G. S., and Dixit, V. M. (1997) J. Biol. Chem. 272, 2952-2956[Abstract/Free Full Text]
  17. Susin, S. A., Zamzami, N., Castedo, M., Daugas, E., Wang, H. G., Geley, S., Fassy, F., Reed, J. C., Kroemer, G. (1997) J. Exp. Med. 186, 25-37[Abstract/Free Full Text]
  18. Zou, H., Henzel, W. J., Liu, X., Lutschg, A., and Wang, X. (1997) Cell 90, 405-413[Medline] [Order article via Infotrieve]
  19. Hengartner, M. O. (1997) Nature 388, 714-715[CrossRef][Medline] [Order article via Infotrieve]
  20. Ng, F. W. H., Nguyen, M., Kwan, T., Branton, P. E., Nicholson, W. D., Cromlish, J. A., Shore, G. C. (1997) J. Cell Biol. 139, 327-338[Abstract/Free Full Text]
  21. Krajewski, S., Tanaka, S., Takayama, S., Schibler, M., Fenton, W., and Reed, J. C. (1993) Cancer Res. 53, 4701-4714[Abstract]
  22. Nguyen, M., Millar, D. G., Yong, V. W., Korsmeyer, S. J., Shore, G. C. (1993) J. Biol. Chem. 268, 25265-25268[Abstract/Free Full Text]
  23. Gonzalez-Garcia, M., Parez-Ballestero, R., Ding, L., Boise, L. H., Thompson, C. B., Nuñez, G. (1994) Development 120, 3033-3042[Abstract/Free Full Text]
  24. Reed, J. C. (1997) Nature 387, 773-776[CrossRef][Medline] [Order article via Infotrieve]
  25. Tewari, M., and Dixit, V. M. (1996) Curr. Opin. Genet. Dev. 6, 39-44[Medline] [Order article via Infotrieve]
  26. Wallach, D. (1997) Trends Biochem. Sci. 22, 107-109[CrossRef][Medline] [Order article via Infotrieve]
  27. Nagata, S. (1997) Cell 88, 355-365[Medline] [Order article via Infotrieve]
  28. Shaham, S., and Horvitz, H. R. (1996) Cell 86, 201-208[Medline] [Order article via Infotrieve]
  29. Yang, E., and Korsmeyer, S. J. (1996) Blood 88, 386-401[Free Full Text]
  30. Schleiff, E., Shore, G. C., and Goping, I. S. (1997) J. Biol. Chem. 272, 17784-17789[Abstract/Free Full Text]


Copyright © 1998 by The American Society for Biochemistry and Molecular Biology, Inc.